drugset
drugset / Trial / NCT00744237

Study of the Glycemic Effects of Nebivolol Compared With Metoprolol and HCTZ in Diabetic Hypertensive Patients

NCT00744237 ↗

Phase 4 Completed 231 enrolled Forest Laboratories
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will evaluate the effects of nebivolol on glycemic control compared with metoprolol and HCTZ in patients with hypertension and type 2 diabetes mellitus

Timeline

Start
2008-08
Primary completion
2010-07
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochlorothiazide Unknown 12.5 mg Oral
Comparator Hydrochlorothiazide Unknown 25 mg Oral
Comparator Metoprolol ER Unknown 50 mg Oral
Comparator Metoprolol ER Unknown 100 mg Oral
Comparator Metoprolol ER Unknown 200 mg Oral
Comparator Metoprolol ER Unknown 400 mg Oral
Subject Nebivolol Other / unclassified 5 mg Oral
Subject Nebivolol Other / unclassified 10 mg Oral
Subject Nebivolol Other / unclassified 20 mg Oral
Subject Nebivolol Other / unclassified 40 mg Oral

Indications

hypertensive disorder type 2 diabetes mellitus